Karyopharm taps longtime Pfizer, Amgen vet to steer the ship; With Merck in the rearview mirror, Roger Perlmutter stakes his claim to a CEO job — and it's a surprising choice
Like many who work in biopharma, Richard Paulson got started in the field because of a love of science.
Paulson had just finished business school …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
